Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06316245
Other study ID # 2024/178
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 19, 2024
Est. completion date December 19, 2024

Study information

Verified date March 2024
Source Istanbul University
Contact Muserref B Dincer
Phone +905321624712
Email mberildincer@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This prospective observational study aims to compare days alive and out of hospital at 30 days (DAOH-30) in patients with poor or good functional capacity undergoing gastrointestinal surgeries. The investigators are testing the hypothesis that patients with good functional capacity will have longer days alive and out of hospital than those with poor.


Description:

Days Alive and Out of Hospital (DAOH) is a composite patient-centered outcome that integrates three critical clinical outcomes: death, hospital length of stay, and hospital readmission. It is associated with patient comorbidities, surgical complexity, and postoperative complications. Evaluation of functional capacity before noncardiac surgery is recommended to identify the perioperative risks. Duke Activity Status Index (DASI) is one of the tools for determining functional capacity; the scores are between 0 and 58,2, and high scores are related to improved capacity. A DASI score of 34 and below was found to be a risk for moderate to severe complications and new disability. The primary aim is to compare days alive and out of the hospital at 30 days in patients ≤ 34 and above 34 DASI scores. The secondary aims are to evaluate intensive care unit (ICU) need and duration, length of hospital stay, rehospitalization, postoperative complications, morbidity, and mortality in patients with DASI scores ≤ 34 and above 34. Days alive and out of hospital at 90 days will be compared in both groups as a secondary outcome. The investigators will also analyze the possible perioperative factors affecting the days alive and out of the hospital outcome. Before the operation, the patients will answer the DASI questionnaire in the waiting area of the operating theatres. The patients will be divided into two groups according to the DASI score (Poor functional capacity: ≤ 34 points, good functional capacity: above 34 points). Patient and surgical characteristics (comorbidities, American Society of Anesthesiologists physical status classification, laboratory values before the operation, frailty index value, American College of Surgeons Risk Calculator outcomes, surgery type, length of operation, intraoperative complications), ICU need and duration will be recorded. Postoperative complications ( cardiovascular, pulmonary, renal, neurologic, surgical, infectious, and wound ), the Postoperative Morbidity Survey (POMS) related morbidity and mortality on the 30th day will be investigated. Length of hospital stay starting with index surgery, rehospitalization and duration of further stays will be recorded. Days Alive and Out of Hospital at 30 days (DAOH-30) will be calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 30th postoperative day. 90th-day mortality and Days Alive and Out of Hospital at 90 days (DAOH-90) will also be investigated.


Recruitment information / eligibility

Status Recruiting
Enrollment 470
Est. completion date December 19, 2024
Est. primary completion date October 19, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing intermediate and major upper or lower gastrointestinal surgeries (small intestine, colon, rectal, gastric, esophagus) with a predicted hospital stay of more than 24 hours - Patients aged 18 and above - Signed written informed consent - Reaching all perioperative data Exclusion Criteria: - Day case/ambulatory or one overnight hospital stay for minor gastrointestinal and perianal surgeries (hernia repair, hemorrhoidectomy, perianal abscess and fistula, appendectomy) - Hepatobiliary surgeries (hepatectomy, pancreas and gallbladder surgeries) - Patients aged below 18 - Not signed written informed consent - Missing perioperative data

Study Design


Related Conditions & MeSH terms


Intervention

Other:
DASI questionnaire
All patients will answer the DASI questionnaire before surgery. According to their scores, they will be divided into two groups. A score of 34 and below will be considered poor, and above 34 will be considered to have good functional capacity.

Locations

Country Name City State
Turkey Istanbul University Istanbul Medical Faculty, Department of Anesthesiology and Reanimation Istanbul Fatih

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Days alive and out of hospital at 30 days (DAOH-30) It is calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 30th postoperative day. 30 days
Secondary Days alive and out of hospital at 90 days (DAOH-90) It is calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 90th postoperative day. 90 days
Secondary Postoperative complications Cardiovascular, pulmonary, renal, neurologic, surgical, infectious and wound complications 30 days
Secondary The Postoperative Morbidity Survey (POMS) defined morbidity Pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, hematological, wound complications and pain will be examined according to POMS 30 days
Secondary Mortality In and out of hospital mortality 30 days and 90 days
Secondary Intensive care unit (ICU) stay Duration of ICU stay (days) 30 days
Secondary Length of hospital stay after index surgery Length of first hospital stay starting with index surgery (days) 30 days
Secondary Rehospitalization Readmission and hospitalization after first discharge 30 days and 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT05847296 - Effect of Preoperative Sarcopenia on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery
Completed NCT05576675 - Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal Surgery Phase 3
Recruiting NCT00995735 - IMTN Study- International Prospective Multicenter Trial on Clinical NOTES N/A
Completed NCT00732849 - The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery Phase 4
Not yet recruiting NCT06466096 - Correlation Analysis of POD and pNCD in Elderly Patients With Gastrointestinal Neoplasms Based on Rs-fMRI
Recruiting NCT05445024 - Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients N/A
Completed NCT03204344 - Preoperative Oral Carbohydrate and Postoperative Recovery in Diabetic Patients N/A
Completed NCT02135016 - The Effect of Thoracic Epidural Anesthesia With Different Block Level on Propofol Induction Phase 4